Saisheng Pharmaceutical announced that the company's subsidiary, Shenyang Junyuan Pharmaceutical Co., Ltd., recently obtained a “Pharmaceutical Production License” issued by the Liaoning Drug Administration. The change was that the person in charge of quality and quality authorized person was changed from Tian Yuelin to Wang Miao. Other details remained unchanged. This change will help Junyuan Pharmaceutical maintain stable production capacity and ensure normal production and operation, and will not have a significant impact on the company's performance.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.